Table 1 Summary of demographic characteristics.
From: Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia
Control (n = 204) | Schizophrenia (n = 226) | Test-statistic | p-value | |
|---|---|---|---|---|
Age (years) | 34.7 ± 13.6 | 35.6 ± 12.9 | t = −0.71 | 0.28 |
Smoker/Non-smoker | 60/144 | 85/141 | χ2 = 3.23 | 0.073 |
Male/Female | 98/106 | 156/70 | χ2 = 19.5 | <0.001 |
Body surface area (m2) | 1.96 ± 0.27 | 2.04 ± 0.29 | t = 2.56 | 0.011 |
Race | ||||
White | 117 | 93 | ||
Black | 68 | 119 | χ2 = 17.0 | <0.001 |
Asian | 15 | 9 | χ2 = 3.08 | 0.079 |
Other | 4 | 5 | ||
Antipsychotic medicationa | ||||
Typical | — | 25 | ||
Atypical | — | 155 | ||
Combination of typical and atypical | — | 16 | ||
Unmedicated | — | 13 | ||
Antidepressanta | — | 82 | ||
Mood stabilizera | — | 39 | ||
Anticholinergic medicationa | — | 42 | ||
Lipid-lowering medicationa | 9 | 23 | χ2 = 5.47 | 0.019 |
